Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure.
Highlighted with 59 tables and 54 figures, this 141-page report "Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Asia Pacific preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific preventive vaccines market in every aspect of the classification from perspectives of Vaccine Type, Disease, Administration, Patient, and Country.

Based on Vaccine Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Live/Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Conjugate Vaccines
• mRNA Vaccines
• Recombinant Vector Vaccines
• Other Vaccines

Based on Disease, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Pneumococcal Disease
• Poliovirus
• Hepatitis
• Influenza
• Measles, Mumps, and Rubella (MMR)
• Varicella
• Human Papilloma Virus
• COVID-19
• Other Diseases

By Administration, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Intramuscular Route
• Subcutaneous Route
• Oral Route
• Intravenous Injection
• Other Administration Routes

By Patient, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Pediatric Vaccines
o Pneumococcal
o Measles, Mumps, and Rubella (MMR)
o Varicella
o Hepatitis
o Poliovirus
o Haemophilus Influenzae B (HIB)
o Other Diseases
• Adult Vaccines
o Influenza
o Cervical Cancer
o Hepatitis
o Zoster
o Other Diseases

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Vaccine Type, Disease, and Administration over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AstraZeneca plc
Bavarian Nordic A/S
China National Biotec Group Company Ltd.
CSL Ltd.
Daiichi Sankyo Co. Ltd
Emergent BioSolutions Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co.
Moderna Inc.
Novavax, Inc.
Pfizer Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter's Fiver Forces Analysis 44
3 Segmentation of Asia Pacific Market by Vaccine Type 48
3.1 Market Overview by Vaccine Type 48
3.2 Live/Attenuated Vaccines 50
3.3 Inactivated Vaccines 51
3.4 Subunit Vaccines 52
3.5 Toxoid Vaccines 53
3.6 Conjugate Vaccines 54
3.7 mRNA Vaccines 55
3.8 Recombinant Vector Vaccines 56
3.9 Other Vaccines 57
4 Segmentation of Asia Pacific Market by Disease 58
4.1 Market Overview by Disease 58
4.2 Pneumococcal Disease 60
4.3 Poliovirus 61
4.4 Hepatitis 62
4.5 Influenza 63
4.6 Measles, Mumps, and Rubella (MMR) 64
4.7 Varicella 65
4.8 Human Papilloma Virus 66
4.9 COVID-19 67
4.10 Other Diseases 68
5 Segmentation of Asia Pacific Market by Administration 69
5.1 Market Overview by Administration 69
5.2 Intramuscular Route 71
5.3 Subcutaneous Route 72
5.4 Oral Route 73
5.5 Intravenous Injection 74
5.6 Other Administration Routes 75
6 Segmentation of Asia Pacific Market by Patient 76
6.1 Market Overview by Patient 76
6.2 Pediatric Vaccines 78
6.3 Adult Vaccines 80
7 Asia-Pacific Market 2022-2032 by Country 82
7.1 Overview of Asia-Pacific Market 82
7.2 Japan 85
7.3 China 89
7.4 Australia 93
7.5 India 96
7.6 South Korea 99
7.7 Rest of APAC Region 102
8 Competitive Landscape 104
8.1 Overview of Key Vendors 104
8.2 New Product Launch, Partnership, Investment, and M&A 107
8.3 Company Profiles 108
AstraZeneca plc 108
Bavarian Nordic A/S 110
China National Biotec Group Company Ltd. 113
CSL Ltd. 115
Daiichi Sankyo Co. Ltd 117
Emergent BioSolutions Inc. 119
GlaxoSmithKline plc 121
Johnson & Johnson 125
Merck & Co. 127
Moderna Inc. 129
Novavax, Inc. 130
Pfizer Inc. 132
Sanofi SA 136
Takeda Pharmaceutical Co. Ltd. 139
RELATED REPORTS 141

Asia Pacific Vanadium Market Size, Share, Trends & Analysis by Grade Type (FeV40, FeV50, FeV60, FeV80), by Production Process (Aluminothermic Reduction Technique, Silicon Reduction Technique), by Application (Iron and Steel, Chemical, Titanium Alloys, Others), by End User (Automotive Chemical, Energy Storage, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Vanadium Market is poised for substantial growth from 2024 to 2034, driven by increasing demand across various industries and technological advancements in vanadium production. The market is projected to reach USD XX.XX billion by 2034, growing at a comp...

Asia Pacific Vascular Closure Devices Market Size, Share, Trends & Analysis by Type (Active Approximators, Passive Approximators, External Hemostatic Devices), by Access (Femoral Access, Radial Access), by Procedure (Interventional Cardiology, Interventional Radiology) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...

Asia Pacific Anti-Pollution Mask Market Size, Share, Trends & Analysis by Type (Disposable, Reusable), by Filter Type (Combination Filter, Gas and Odour Filter, Particulate Filter), by Distribution Channel (Online, Offline) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Anti-Pollution Mask Market is set to experience substantial growth from 2024 to 2034. Starting with a market valuation of USD XX.XX billion in 2024, it is projected to reach USD XX.XX billion by 2034, reflecting a significant compound annual growth rate ...

Asia Pacific Ethnic Wear Market Size, Share, Trends & Analysis by End User (Men, Women, Children), by Type (Fusion Wear, Traditional Wear), by Distribution Channel (Online, Offline) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Ethnic Wear Market is anticipated to experience robust growth from 2024 to 2034. Starting with a market valuation of USD XX.XX billion in 2024, it is projected to surge to USD XX.XX billion by 2034, reflecting a strong compound annual growth rate (CAGR) ...

Asia Pacific FinTech Investment Market Size, Share, Trends & Analysis by Product Type (P2P Lending, Online Acquiring & Mobile Wallets, Personal Finance Management, MSME Services, MPOS, Mobile First Banking, Bitcoin, Crowdfunding, Others), by Technology (Internet of Things (IoT), Artificial Intelligence, 5G, Big Data, Blockchain, Open Banking, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific FinTech Investment Market is poised for significant expansion from 2024 to 2034. With an initial valuation of USD XX.XX billion in 2024, the market is forecasted to reach USD XX.XX billion by 2034, reflecting a robust compound annual growth rate (CAGR) o...

Asia Pacific Airport Asset Tracking Market Size, Share, Trends & Analysis by Offering (Hardware, Software), by Asset Type (Fixed Assets, Portable Assets, Mobile Assets) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Airport Asset Tracking Market is anticipated to witness significant growth from 2024 to 2034, propelled by the increasing need for efficient asset management and operational visibility in the aviation sector. The market is projected to reach USD XX.XX bi...

Asia Pacific Sustainable Aviation Fuel Market Size, Share, Trends & Analysis by Technology (FT-SPK, HEFA-SPK, HFS-SIP, ATJ-SPK, CHJ, FT-SPK/A, HC-HEFA-SPK), by Fuel Type (Biofuel, Hydrogen Fuel, Power to Liquid, Gas to Liquid), by Platform (Commercial Aviation, Military Aviation, Business & General Aviation, Unmanned Aerial Vehicles), by Blending Capacity (Below 30%, 30% to 50%, Above 50%) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Sustainable Aviation Fuel Market is positioned for substantial growth from 2024 to 2034, driven by escalating environmental regulations, increasing corporate sustainability initiatives, and a growing emphasis on reducing aviation carbon emissions. The ma...

Asia Pacific Integrated Facility Management Market Size, Share, Trends & Analysis by Type (Hard Service, Soft Service), by Service (Building & Property Management, Cleaning & Hygiene, Security & Staffing, IT Support, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Integrated Facility Management Market is projected for substantial growth from 2024 to 2034. Valued at USD XX.XX billion in 2024, the market is anticipated to reach USD XX.XX billion by 2034, reflecting a robust compound annual growth rate (CAGR) of XX.X...

Asia Pacific Smart Air Conditioner Market Size, Share, Trends & Analysis by Product (Temperature Control, Humidity Control, Ventilation Control, Integrated Control), by Application (Residential Buildings, Industrial Buildings, Commercial Buildings) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Smart Air Conditioner Market is set for significant expansion from 2024 to 2034. Valued at USD XX.XX billion in 2024, the market is projected to reach USD XX.XX billion by 2034, reflecting a robust compound annual growth rate (CAGR) of XX.XX%. This promi...